Sending Office: Trahan, Lori
Sent By:

The Medication Access and Training Expansion (MATE) Act

Introduced by Representatives Lori Trahan (D-MA), Jack Bergman (R-MI),
Buddy Carter (R-GA), David Trone (D-MD), Hal Rogers (R-KY), and Annie Kuster (D-NH)

Endorsed by the American Society of Addiction Medicine, National Council for Behavioral Health, The Kennedy Forum, National Safety Council, Partnership for Drug-Free Kids + Center on Addiction, Shatterproof, SMART Recovery, Faces and Voices
of Recovery, Young People in Recovery, CADA of Northwest Louisiana, Connecticut Certification Board,
National Association of Addiction Treatment Providers, and American College of Medical Toxicology (ACMT)


According to the CDC, we have lost more than 700,000 Americans from a drug overdose since 1999.[1] Stigma and lack of understanding about addiction, which persists even within the medical community, have prevented
far too many people from accessing evidence-based care for this chronic, treatable disease.

To address this crisis, we must take a comprehensive, multi-pronged approach to strengthening the infrastructure around addiction treatment, which includes strategies to equip medical professionals across the health care continuum to recognize and treat addiction.
This starts with standardizing and mainstreaming access to addiction treatment medications and training on how to integrate them into medical practice.

Prescribers of DEA controlled substances are often the first practitioners to interact with and provide interventional care for individuals with substance use disorders (SUD), and yet they lack adequate education or training in addiction.

  • FACT: According to a recent Shatterproof survey, only 1 in 4 surveyed providers had received training on addiction during their medical education[2]
  • FACT: Only about 5% of all physicians, 4% of nurse practitioners (NPs), and 2% of physician assistants (PAs) have obtained a waiver necessary to prescribe medication assisted treatments (MAT) like buprenorphine, which has led to 90-95%
    of people with SUD without treatment
  • FACT: Training is currently voluntary and offered through the Substance Abuse and Mental Health Services Administration (SAMHSA) and other expert-led organizations for


  • Ensure that all DEA controlled medication prescribers (Schedule II, III, IV or V) have baseline knowledge on how to prevent, identify, treat, and manage patients with SUD
  • Create a one-time, non-repetitive training requirement for prescribers on treating and managing patients with SUD, unless a prescriber is otherwise qualified
  • Allow accredited medical schools and residency programs, physician assistant schools, and schools of advanced practice nursing to fulfill the training requirement through comprehensive curriculum that meets the standards laid out in statute, without having
    to coordinate the development of their education with an outside medical society or state licensing body
  • Normalize addiction medicine education across professional schools and phase out the need for future practitioners to take a separate, federally mandated addiction training course
  • Satisfy the DATA 2000 X-waiver training requirement to prescribe addiction medications, like buprenorphine, as long as a separate DATA 2000 X-waiver is required by law

For questions on this bipartisan legislation, please contact

Related Legislative Issues

Selected legislative information: HealthCare, Judiciary

Related Bill Information

Bill Type: H.R.
Bill Number: 4974
Special Note:

icon eDC logo e-Dear Colleague version 2.0
e-Dear Colleagues are intended for internal House use only.